Clinical Trial Update: Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). [Phase 2]

View source ↗

Summary

Phase 2 study of CIN-103 in adults with irritable bowel syndrome with diarrhea was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• CIN-103

Snippet

Sponsor: CinPhloro Pharma, LLC | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 2 | Status: TERMINATED